Cargando…

Methodological choices affect cancer incidence rates: a cohort study

BACKGROUND: Incidence rates are fundamental to epidemiology, but their magnitude and interpretation depend on methodological choices. We aimed to examine the extent to which the definition of the study population affects cancer incidence rates. METHODS: All primary cancer diagnoses in Sweden between...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooke, Hannah L., Talbäck, Mats, Feychting, Maria, Ljung, Rickard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248500/
https://www.ncbi.nlm.nih.gov/pubmed/28103940
http://dx.doi.org/10.1186/s12963-017-0120-x
_version_ 1782497280501219328
author Brooke, Hannah L.
Talbäck, Mats
Feychting, Maria
Ljung, Rickard
author_facet Brooke, Hannah L.
Talbäck, Mats
Feychting, Maria
Ljung, Rickard
author_sort Brooke, Hannah L.
collection PubMed
description BACKGROUND: Incidence rates are fundamental to epidemiology, but their magnitude and interpretation depend on methodological choices. We aimed to examine the extent to which the definition of the study population affects cancer incidence rates. METHODS: All primary cancer diagnoses in Sweden between 1958 and 2010 were identified from the national Cancer Register. Age-standardized and age-specific incidence rates of 29 cancer subtypes between 2000 and 2010 were calculated using four definitions of the study population: persons resident in Sweden 1) based on general population statistics; 2) with no previous subtype-specific cancer diagnosis; 3) with no previous cancer diagnosis except non-melanoma skin cancer; and 4) with no previous cancer diagnosis of any type. We calculated absolute and relative differences between methods. RESULTS: Age-standardized incidence rates calculated using general population statistics ranged from 6% lower (prostate cancer, incidence rate difference: -13.5/100,000 person-years) to 8% higher (breast cancer in women, incidence rate difference: 10.5/100,000 person-years) than incidence rates based on individuals with no previous subtype-specific cancer diagnosis. Age-standardized incidence rates in persons with no previous cancer of any type were up to 10% lower (bladder cancer in women) than rates in those with no previous subtype-specific cancer diagnosis; however, absolute differences were <5/100,000 person-years for all cancer subtypes. CONCLUSIONS: For some cancer subtypes incidence rates vary depending on the definition of the study population. For these subtypes, standardized incidence ratios calculated using general population statistics could be misleading. Moreover, etiological arguments should be used to inform methodological choices during study design. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-017-0120-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5248500
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52485002017-01-25 Methodological choices affect cancer incidence rates: a cohort study Brooke, Hannah L. Talbäck, Mats Feychting, Maria Ljung, Rickard Popul Health Metr Research BACKGROUND: Incidence rates are fundamental to epidemiology, but their magnitude and interpretation depend on methodological choices. We aimed to examine the extent to which the definition of the study population affects cancer incidence rates. METHODS: All primary cancer diagnoses in Sweden between 1958 and 2010 were identified from the national Cancer Register. Age-standardized and age-specific incidence rates of 29 cancer subtypes between 2000 and 2010 were calculated using four definitions of the study population: persons resident in Sweden 1) based on general population statistics; 2) with no previous subtype-specific cancer diagnosis; 3) with no previous cancer diagnosis except non-melanoma skin cancer; and 4) with no previous cancer diagnosis of any type. We calculated absolute and relative differences between methods. RESULTS: Age-standardized incidence rates calculated using general population statistics ranged from 6% lower (prostate cancer, incidence rate difference: -13.5/100,000 person-years) to 8% higher (breast cancer in women, incidence rate difference: 10.5/100,000 person-years) than incidence rates based on individuals with no previous subtype-specific cancer diagnosis. Age-standardized incidence rates in persons with no previous cancer of any type were up to 10% lower (bladder cancer in women) than rates in those with no previous subtype-specific cancer diagnosis; however, absolute differences were <5/100,000 person-years for all cancer subtypes. CONCLUSIONS: For some cancer subtypes incidence rates vary depending on the definition of the study population. For these subtypes, standardized incidence ratios calculated using general population statistics could be misleading. Moreover, etiological arguments should be used to inform methodological choices during study design. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-017-0120-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-19 /pmc/articles/PMC5248500/ /pubmed/28103940 http://dx.doi.org/10.1186/s12963-017-0120-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Brooke, Hannah L.
Talbäck, Mats
Feychting, Maria
Ljung, Rickard
Methodological choices affect cancer incidence rates: a cohort study
title Methodological choices affect cancer incidence rates: a cohort study
title_full Methodological choices affect cancer incidence rates: a cohort study
title_fullStr Methodological choices affect cancer incidence rates: a cohort study
title_full_unstemmed Methodological choices affect cancer incidence rates: a cohort study
title_short Methodological choices affect cancer incidence rates: a cohort study
title_sort methodological choices affect cancer incidence rates: a cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248500/
https://www.ncbi.nlm.nih.gov/pubmed/28103940
http://dx.doi.org/10.1186/s12963-017-0120-x
work_keys_str_mv AT brookehannahl methodologicalchoicesaffectcancerincidenceratesacohortstudy
AT talbackmats methodologicalchoicesaffectcancerincidenceratesacohortstudy
AT feychtingmaria methodologicalchoicesaffectcancerincidenceratesacohortstudy
AT ljungrickard methodologicalchoicesaffectcancerincidenceratesacohortstudy